Abstract
Background Despite extensive research on the risk factors for breast cancer, little is known about the factors contributing to other breast lesions, of which some may indicate an increased risk for this disease. The objective of this study was to identify the risk factors for breast lesions among women with breast lumps seeking care at select teaching and referral hospitals in Kenya between December 2016 to December 2019.
Methods An analytical cross-sectional study design was used to investigate the risk factors for breast lesions among 651 women with breast lumps. Data was collected using a semi-structured questionnaire. A multivariable logistic regression model was used to evaluate the impact of the predictors on the breast lesions. Ethical approval was granted by Kenyatta National Hospital (KNH) and the University of Nairobi Ethics and Research Committee (UoN-ERC) under study number P334/04/2016.
Results The median age of participants was 30 years (range 16-87), with the majority having secondary education and belonging to the Kikuyu ethnic group. Parity, exercise, and contraceptive use were significant predictors of breast lesions identified. Nulliparous women had significantly lower odds of developing malignant (aOR: 0.11; 95% CI: 0.05-0.26), and suspicious (aOR: 0.23; 95% CI: 0.07-0.71) lesions. Regular exercise was associated with lower odds of both malignant and suspicious lesions. Conversely, contraceptive use increased the odds of developing atypical (aOR 0.92; 95% CI: 0.28-2.98) lesions, suspicious (aOR 0.33; 95% CI: 0.14-0.78), and malignant lesions (aOR of 0.31; 95% CI: 0.18-0.55).
Conclusion Exercise, parity, and hormonal contraception were independently found to be significant predictors of breast lesions. These findings underscore the necessity for personalized risk reduction strategies and emphasize the importance of understanding the risk factors for both benign and malignant breast disease to inform public health policies.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Yes
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Approval to conduct this study was granted by the Kenyatta National Hospital and the University of Nairobi Ethics and Research Committee (study no. P334/04/2016)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The data underlying the results presented in the study are available in Harvard Dataverse. https://doi.org/10.7910/DVN/2OXWTA.
